{
  "DOI": "10.1038/ejhg.2013.66",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2013.66",
  "alternative-id": [
    "BFejhg201366"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Corso",
      "given": "Giovanni",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Pascale",
      "given": "Valeria",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Flauti",
      "given": "Giuseppe",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ferrara",
      "given": "Francesco",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Marrelli",
      "given": "Daniele",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Roviello",
      "given": "Franco",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2013,
        4,
        10
      ]
    ],
    "date-time": "2013-04-10T10:20:37Z",
    "timestamp": 1365589237000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:10:41Z",
    "timestamp": 1684429841000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        2
      ]
    ],
    "date-time": "2023-09-02T01:32:58Z",
    "timestamp": 1693618378190
  },
  "is-referenced-by-count": 19,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "12",
  "issued": {
    "date-parts": [
      [
        2013,
        4,
        10
      ]
    ]
  },
  "journal-issue": {
    "issue": "12",
    "published-print": {
      "date-parts": [
        [
          2013,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2013,
            4,
            10
          ]
        ],
        "date-time": "2013-04-10T00:00:00Z",
        "timestamp": 1365552000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg201366.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg201366",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg201366.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1383-1388",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2013,
        4,
        10
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2013,
        4,
        10
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2013,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1080/15216540600746393",
      "author": "M Imajo",
      "doi-asserted-by": "publisher",
      "first-page": "312",
      "journal-title": "IUBMB Life",
      "key": "BFejhg201366_CR1",
      "unstructured": "Imajo M, Tsuchiya Y, Nishida E : Regulatory mechanisms and functions of MAP kinase signaling pathways. IUBMB Life 2006; 58: 312–317.",
      "volume": "58",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S0021-9258(19)38983-5",
      "author": "G Carpenter",
      "doi-asserted-by": "crossref",
      "first-page": "7709",
      "journal-title": "J Biol Chem",
      "key": "BFejhg201366_CR2",
      "unstructured": "Carpenter G, Cohen S : Epidermal growth factor. J Biol Chem 1990; 265: 7709–7712.",
      "volume": "265",
      "year": "1990"
    },
    {
      "DOI": "10.1073/pnas.89.4.1330",
      "author": "XL Quian",
      "doi-asserted-by": "publisher",
      "first-page": "1330",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg201366_CR3",
      "unstructured": "Quian XL, Decker SJ, Greene MI : p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases. Proc Natl Acad Sci USA 1992; 89: 1330–1334.",
      "volume": "89",
      "year": "1992"
    },
    {
      "author": "TJ Lynch",
      "first-page": "786",
      "journal-title": "Clin Adv Hematol Oncol",
      "key": "BFejhg201366_CR4",
      "unstructured": "Lynch TJ : The evolving story of the epidermal growth factor receptor as a target for non-small-cell lung cancer. Clin Adv Hematol Oncol 2004; 2: 786–787.",
      "volume": "2",
      "year": "2004"
    },
    {
      "DOI": "10.1200/JCO.2008.18.7286",
      "author": "S Artale",
      "doi-asserted-by": "publisher",
      "first-page": "4217",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg201366_CR5",
      "unstructured": "Artale S, Sartore-Bianchi A, Veronese SM et al: Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer. J Clin Oncol 2008; 26: 4217–4219.",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2009.21.9170",
      "author": "CJ Allegra",
      "doi-asserted-by": "publisher",
      "first-page": "2091",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg201366_CR6",
      "unstructured": "Allegra CJ, Jessup JM, Somerfield MR et al: American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 2009; 27: 2091–2096.",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2008.20.1525",
      "author": "S Velho",
      "doi-asserted-by": "publisher",
      "first-page": "158",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg201366_CR7",
      "unstructured": "Velho S, Oliveira C, Seruca R : KRAS mutations and anti-epidermal growth factor receptor therapy in colorectal cancer with lymph node metastases. J Clin Oncol 2009; 27: 158–159.",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1097/SLA.0b013e3181bc9d96",
      "author": "LC Yen",
      "doi-asserted-by": "publisher",
      "first-page": "254",
      "journal-title": "Ann Surg",
      "key": "BFejhg201366_CR8",
      "unstructured": "Yen LC, Uen YH, Wu DC et al: Activating KRAS mutations and overexpression of epidermal growth factor receptor as independent predictors in metastatic colorectal cancer patients treated with cetuximab. Ann Surg 2010; 251: 254–260.",
      "volume": "251",
      "year": "2010"
    },
    {
      "DOI": "10.1186/1471-2350-12-144",
      "author": "B Metzger",
      "doi-asserted-by": "publisher",
      "first-page": "144",
      "journal-title": "BMC Med Genet",
      "key": "BFejhg201366_CR9",
      "unstructured": "Metzger B, Chambeau L, Begon DY et al: The human epidermal growth factor receptor (EGFR) gene in European patients with advanced colorectal cancer harbors infrequent mutations in its tyrosine kinase domain. BMC Med Genet 2011; 12: 144.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-1894",
      "author": "H Nagahara",
      "doi-asserted-by": "publisher",
      "first-page": "1368",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg201366_CR10",
      "unstructured": "Nagahara H, Mimori K, Ohta M et al: Somatic mutations of epidermal growth factor receptor in colorectal carcinoma. Clin Cancer Res 2005; 11: 1368–1371.",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-0986",
      "author": "Z Yuan",
      "doi-asserted-by": "publisher",
      "first-page": "7811",
      "journal-title": "Cancer Res",
      "key": "BFejhg201366_CR11",
      "unstructured": "Yuan Z, Shin J, Wilson A et al: An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression. Cancer Res 2009; 69: 7811–7818.",
      "volume": "69",
      "year": "2009"
    },
    {
      "DOI": "10.5858/arpa.2010-0638-OA",
      "author": "M Deqin",
      "doi-asserted-by": "publisher",
      "first-page": "510",
      "journal-title": "Arch Pathol Lab Med",
      "key": "BFejhg201366_CR12",
      "unstructured": "Deqin M, Chen Z, Nero C et al: Somatic deletions of the polyA tract in the 3′ untranslated region of epidermal growth factor receptor are common in microsatellite instability-high endometrial and colorectal carcinomas. Arch Pathol Lab Med 2012; 136: 510–516.",
      "volume": "136",
      "year": "2012"
    },
    {
      "DOI": "10.1016/B978-0-12-380890-5.00004-1",
      "author": "S Velho",
      "doi-asserted-by": "publisher",
      "first-page": "123",
      "journal-title": "Adv Cancer Res",
      "key": "BFejhg201366_CR13",
      "unstructured": "Velho S, Corso G, Oliveíra C, Seruca R : KRAS signaling pathway alterations in microsatellite unstable gastrointestinal cancers. Adv Cancer Res 2010; 109: 123–143.",
      "volume": "109",
      "year": "2010"
    },
    {
      "DOI": "10.1002/ijc.22829",
      "author": "M Miyaki",
      "doi-asserted-by": "publisher",
      "first-page": "1627",
      "journal-title": "Int J Cancer",
      "key": "BFejhg201366_CR14",
      "unstructured": "Miyaki M, Iijima T, Yamaguchi T et al: Mutations of the PIK3CA gene in hereditary colorectal cancers. Int J Cancer 2007; 121: 1627–1630.",
      "volume": "121",
      "year": "2007"
    },
    {
      "DOI": "10.1093/carcin/bgs203",
      "author": "P Gulhati",
      "doi-asserted-by": "publisher",
      "first-page": "1782",
      "journal-title": "Carcinogenesis",
      "key": "BFejhg201366_CR15",
      "unstructured": "Gulhati P, Zaytseva YY, Valentino JD et al: Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA. Carcinogenesis 2012; 33: 1782–1790.",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ejca.2010.09.008",
      "author": "G Corso",
      "doi-asserted-by": "publisher",
      "first-page": "443",
      "journal-title": "Eur J Cancer",
      "key": "BFejhg201366_CR16",
      "unstructured": "Corso G, Velho S, Paredes J et al: Oncogenic mutations in gastric cancer with microsatellite instability. Eur J Cancer 2011; 47: 443–451.",
      "volume": "47",
      "year": "2011"
    },
    {
      "DOI": "10.1001/archsurg.2009.42",
      "author": "G Corso",
      "doi-asserted-by": "publisher",
      "first-page": "722",
      "journal-title": "Arch Surg",
      "key": "BFejhg201366_CR17",
      "unstructured": "Corso G, Pedrazzani C, Marrelli D, Pascale V, Pinto E, Roviello F : Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma. Arch Surg 2009; 144: 722–727.",
      "volume": "144",
      "year": "2009"
    },
    {
      "DOI": "10.2105/AJPH.2011.300393",
      "author": "AI Phipps",
      "doi-asserted-by": "publisher",
      "first-page": "1791",
      "journal-title": "Am J Public Health",
      "key": "BFejhg201366_CR18",
      "unstructured": "Phipps AI, Scoggins J, Rossing MA, Li CI, Newcomb PA : Temporal trends in incidence and mortality rates for colorectal cancer by tumor location: 1975-2007. Am J Public Health 2012; 102: 1791–1797.",
      "volume": "102",
      "year": "2012"
    },
    {
      "DOI": "10.1097/DCR.0b013e31823c08b3",
      "author": "MF Kalady",
      "doi-asserted-by": "publisher",
      "first-page": "128",
      "journal-title": "Dis Colon Rectum",
      "key": "BFejhg201366_CR19",
      "unstructured": "Kalady MF, Dejulius KL, Sanchez JA et al: BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Dis Colon Rectum 2012; 55: 128–133.",
      "volume": "55",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s11606-010-1460-4",
      "author": "R Wong",
      "doi-asserted-by": "publisher",
      "first-page": "1157",
      "journal-title": "J Gen Intern Med",
      "key": "BFejhg201366_CR20",
      "unstructured": "Wong R : Proximal tumors are associated with greater mortality in colon cancer. J Gen Intern Med 2010; 25: 1157–1163.",
      "volume": "25",
      "year": "2010"
    },
    {
      "DOI": "10.1631/jzus.B0820273",
      "author": "FY Li",
      "doi-asserted-by": "publisher",
      "first-page": "219",
      "journal-title": "J Zhejiang Univ Sci B",
      "key": "BFejhg201366_CR21",
      "unstructured": "Li FY, Lai MD : Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 2009; 10: 219–229.",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ejso.2010.12.004",
      "author": "F Benedix",
      "doi-asserted-by": "publisher",
      "first-page": "134",
      "journal-title": "Eur J Surg Oncol",
      "key": "BFejhg201366_CR22",
      "unstructured": "Benedix F, Schmidt U, Mroczkowski P, Gastinger I, Lippert H, Kube R : Study Group ‘Colon/Rectum Carcinoma (Primary Tumor)’: Colon carcinoma—classification into right and left sided cancer or according to colonic subsite?—Analysis of 29,568 patients. Eur J Surg Oncol 2011; 37: 134–139.",
      "volume": "37",
      "year": "2011"
    },
    {
      "DOI": "10.1093/hmg/ddh238",
      "author": "C Oliveira",
      "doi-asserted-by": "publisher",
      "first-page": "2303",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg201366_CR23",
      "unstructured": "Oliveira C, Westra JL, Arango D et al: Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status. Hum Mol Genet 2004; 13: 2303–2311.",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-11-1397",
      "author": "BE Sylvester",
      "doi-asserted-by": "publisher",
      "first-page": "350",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg201366_CR24",
      "unstructured": "Sylvester BE, Huo D, Khramtsov A et al: Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution. Clin Cancer Res 2012; 18: 350–359.",
      "volume": "18",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2009.23.3452",
      "author": "AD Roth",
      "doi-asserted-by": "publisher",
      "first-page": "466",
      "journal-title": "J Clin Oncol",
      "key": "BFejhg201366_CR25",
      "unstructured": "Roth AD, Tejpar S, Delorenzi M et al: Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J Clin Oncol 2010; 28: 466–474.",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-12-0545",
      "author": "J Webster",
      "doi-asserted-by": "publisher",
      "first-page": "91",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BFejhg201366_CR26",
      "unstructured": "Webster J, Kauffman TL, Spencer Feigelson H et al: KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev 2012; 22: 91–101.",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s00384-007-0423-7",
      "author": "G Cai",
      "doi-asserted-by": "publisher",
      "first-page": "365",
      "journal-title": "Int J Colorectal Dis",
      "key": "BFejhg201366_CR27",
      "unstructured": "Cai G, Xu Y, Lu H et al: Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers. Int J Colorectal Dis 2008; 23: 365–373.",
      "volume": "23",
      "year": "2008"
    },
    {
      "DOI": "10.1056/NEJM200001133420201",
      "author": "R Gryfe",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "journal-title": "N Engl J Med",
      "key": "BFejhg201366_CR28",
      "unstructured": "Gryfe R, Kim H, Hsieh ET et al: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342: 69–77.",
      "volume": "342",
      "year": "2000"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-07-0366",
      "author": "A Malesci",
      "doi-asserted-by": "publisher",
      "first-page": "3831",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg201366_CR29",
      "unstructured": "Malesci A, Laghi L, Bianchi P et al: Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer. Clin Cancer Res 2007; 13: 3831–3839.",
      "volume": "13",
      "year": "2007"
    },
    {
      "DOI": "10.1023/B:FAME.0000039915.94550.cc",
      "author": "AJ Clark",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "journal-title": "Fam Cancer",
      "key": "BFejhg201366_CR30",
      "unstructured": "Clark AJ, Barnetson R, Farrington SM, Dunlop MG : Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent? Fam Cancer 2004; 3: 85–91.",
      "volume": "3",
      "year": "2004"
    },
    {
      "DOI": "10.1002/ijc.11176",
      "author": "CN Arnold",
      "doi-asserted-by": "publisher",
      "first-page": "66",
      "journal-title": "Int J Cancer",
      "key": "BFejhg201366_CR31",
      "unstructured": "Arnold CN, Goel A, Boland CR : Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Int J Cancer 2003; 106: 66–73.",
      "volume": "106",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0016-5085(99)70558-5",
      "author": "JM Carethers",
      "doi-asserted-by": "publisher",
      "first-page": "123",
      "journal-title": "Gastroenterology",
      "key": "BFejhg201366_CR32",
      "unstructured": "Carethers JM, Chauhan DP, Fink D et al: Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology 1999; 117: 123–131.",
      "volume": "117",
      "year": "1999"
    },
    {
      "DOI": "10.1053/j.gastro.2003.12.023",
      "author": "JM Carethers",
      "doi-asserted-by": "publisher",
      "first-page": "394",
      "journal-title": "Gastroenterology",
      "key": "BFejhg201366_CR33",
      "unstructured": "Carethers JM, Smith EJ, Behling CA et al: Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology 2004; 126: 394–401.",
      "volume": "126",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s11523-008-0103-8",
      "author": "G Des Guetz",
      "doi-asserted-by": "publisher",
      "first-page": "57",
      "journal-title": "Target Oncol",
      "key": "BFejhg201366_CR34",
      "unstructured": "Des Guetz G, Uzzan B, Nicolas P, Schischmanoff O, Morere JF : Microsatellite instability: a predictive marker in metastatic colorectal cancer? Target Oncol 2009; 4: 57–62.",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ejca.2009.04.018",
      "author": "G Des Guetz",
      "doi-asserted-by": "publisher",
      "first-page": "1890",
      "journal-title": "Eur J Cancer",
      "key": "BFejhg201366_CR35",
      "unstructured": "Des Guetz G, Schischmanoff O, Nicolas P, Perret GY, Morere JF, Uzzan B : Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. Eur J Cancer 2009; 45: 1890–1896.",
      "volume": "45",
      "year": "2009"
    },
    {
      "author": "G Des Guetz",
      "first-page": "1615",
      "journal-title": "Anticancer Res",
      "key": "BFejhg201366_CR36",
      "unstructured": "Des Guetz G, Uzzan B, Nicolas P, Schischmanoff O, Perret GY, Morere JF : Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer? A systematic review and meta-analysis. Anticancer Res 2009; 29: 1615–1620.",
      "volume": "29",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMoa022289",
      "author": "CM Ribic",
      "doi-asserted-by": "publisher",
      "first-page": "247",
      "journal-title": "N Engl J Med",
      "key": "BFejhg201366_CR37",
      "unstructured": "Ribic CM, Sargent DJ, Moore MJ et al: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349: 247–257.",
      "volume": "349",
      "year": "2003"
    },
    {
      "DOI": "10.1097/CCO.0b013e32832c94bd",
      "author": "FA Sinicrope",
      "doi-asserted-by": "publisher",
      "first-page": "369",
      "journal-title": "Curr Opin Oncol",
      "key": "BFejhg201366_CR38",
      "unstructured": "Sinicrope FA, Sargent DJ : Clinical implications of microsatellite instability in sporadic colon cancers. Curr Opin Oncol 2009; 21: 369–373.",
      "volume": "21",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.onc.1207061",
      "author": "C Oliveira",
      "doi-asserted-by": "publisher",
      "first-page": "9192",
      "journal-title": "Oncogene",
      "key": "BFejhg201366_CR39",
      "unstructured": "Oliveira C, Pinto M, Duval A et al: BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency. Oncogene 2003; 22: 9192–9196.",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1186/bcr803",
      "author": "IG Campbell",
      "doi-asserted-by": "publisher",
      "first-page": "R366",
      "journal-title": "Breast Cancer Res",
      "key": "BFejhg201366_CR40",
      "unstructured": "Campbell IG, Choong D, Chenevix-Trench G : Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer: No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer. Breast Cancer Res 2004; 6: R366–R371.",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.4161/cc.3.10.1164",
      "author": "Y Samuels",
      "doi-asserted-by": "publisher",
      "first-page": "1221",
      "journal-title": "Cell Cycle",
      "key": "BFejhg201366_CR41",
      "unstructured": "Samuels Y, Velculescu VE : Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 2004; 3: 1221–1224.",
      "volume": "3",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.ejca.2005.04.022",
      "author": "S Velho",
      "doi-asserted-by": "publisher",
      "first-page": "1649",
      "journal-title": "Eur J Cancer",
      "key": "BFejhg201366_CR42",
      "unstructured": "Velho S, Oliveira C, Ferreira A et al: The prevalence of PIK3CA mutations in gastric and colon cancer. Eur J Cancer 2005; 41: 1649–1654.",
      "volume": "41",
      "year": "2005"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-11-2410",
      "author": "X Liao",
      "doi-asserted-by": "publisher",
      "first-page": "2257",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg201366_CR43",
      "unstructured": "Liao X, Morikawa T, Lochhead P et al: Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review. Clin Cancer Res 2012; 18: 2257–2268.",
      "volume": "18",
      "year": "2012"
    }
  ],
  "reference-count": 43,
  "references-count": 43,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg201366"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients"
  ],
  "type": "journal-article",
  "volume": "21"
}